{"nct_id":"NCT06469944","title":"Substudy 06C: A Study of Sacituzumab Tirumotecan (MK-2870) With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2024-09-20","start_date_type":"ACTUAL","primary_completion_date":"2027-01-17","primary_completion_date_type":"ESTIMATED","completion_date":"2029-04-12","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}